DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, announced today that David Bupp, its President and CEO, will be interviewed live on Market News First (www.mn1.com) later today at 12:45PM EDT. Mr. Bupp is expected to discuss recent Company events as well as the clinical and regulatory status of the Company’s Lymphoseek® drug initiative.
